Viewing Study NCT06986057


Ignite Creation Date: 2025-12-24 @ 6:42 PM
Ignite Modification Date: 2026-04-13 @ 5:54 PM
Study NCT ID: NCT06986057
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-22
First Post: 2025-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer
Sponsor: Shandong Tumor Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Cancer View
None Neoadjuvant Therapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None immunotherapy View
None PD-1 Inhibitor View
None CTLA-4 Inhibitor View